Industry executive proposes two support groups to assist the Commission in its work
This article was originally published in Clinica
The European Commission could benefit from two new support bodies to help with directive implementation issues and monitoring notified bodies, according to Malcolm Carlisle of Smiths Industries Medical Systems.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.